Clinical Trials Browser

Phase 2 × Erlotinib Hydrochloride × Myeloid × Clear all

NCT01038856 2020-08-24

OSI-TAR-766

Phase 2 Terminated

5 enrolled 6 charts

Polycythemia Vera

NCT00977548 2013-09-16

Erlotinib Study for Myelodysplastic Syndrome (MDS)

Phase 2 Completed

39 enrolled 10 charts

MyeloidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Myelodysplastic Syndromes